Benzonatate
苯佐那酯
Report date: 2022/03/10 16:13:14
NME
Base Information
Drug NameBenzonatate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1958/02/10
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer IncCspc-Nbp Pharmaceutical Co Ltd
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active Indications
Inactive IndicationsN/A